Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
insulin receptor | 0.432 | 0.846 | 3.6E-05 |
|
disease | 0.700 | None | 0.962 | 5 | 0 | 1985 | 2020 | ||||||||
|
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 | 0.529 | 0.808 | 1.00 |
|
disease | 0.510 | None | 1.000 | 3 | 0 | 2005 | 2016 | ||||||||
|
mitogen-activated protein kinase 3 | 0.379 | 0.885 | 3.7E-02 |
|
disease | 0.250 | None | 1.000 | 3 | 0 | 2009 | 2018 | ||||||||
|
mitogen-activated protein kinase 1 | 0.330 | 0.923 | 1.00 |
|
disease | 0.300 | None | 1.000 | 3 | 0 | 2008 | 2020 | ||||||||
|
serpin family E member 1 | 0.359 | 0.885 | 4.4E-02 |
|
disease | 0.300 | None | 0.922 | 2 | 0 | 1994 | 2020 | ||||||||
|
serpin family F member 1 | 0.460 | 0.846 | 7.8E-08 |
|
disease | 0.300 | None | 0.923 | 2 | 0 | 2007 | 2020 | ||||||||
|
proprotein convertase subtilisin/kexin type 1 | 0.548 | 0.615 | 2.7E-09 |
|
disease | 0.300 | None | 0.800 | 2 | 0 | 1996 | 2019 | ||||||||
|
insulin receptor substrate 1 | 0.488 | 0.769 | 2.4E-02 |
|
disease | 0.900 | None | 0.939 | 2 | 0 | 1993 | 2019 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.300 | None | 0.944 | 2 | 0 | 2001 | 2019 | ||||||||
|
plasminogen activator, tissue type | 0.445 | 0.885 | 5.7E-05 |
|
disease | 0.210 | None | 1.000 | 2 | 0 | 2000 | 2020 | ||||||||
|
insulin like growth factor 1 receptor | 0.399 | 0.885 | 0.97 |
|
disease | 0.270 | None | 0.875 | 2 | 0 | 2000 | 2018 | ||||||||
|
calpain 10 | 0.621 | 0.577 | 6.9E-13 |
|
disease | 0.700 | None | 0.926 | 2 | 0 | 2000 | 2019 | ||||||||
|
CREB regulated transcription coactivator 2 | 0.633 | 0.538 | 1.00 |
|
disease | 0.240 | None | 1.000 | 2 | 0 | 2005 | 2019 | ||||||||
|
PPARG coactivator 1 alpha | 0.453 | 0.885 | 1.00 |
|
disease | 0.600 | None | 0.925 | 2 | 0 | 2001 | 2020 | ||||||||
|
uncoupling protein 2 | 0.493 | 0.808 | 1.5E-10 |
|
disease | 0.600 | None | 0.857 | 2 | 0 | 1998 | 2019 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2002 | 2018 | ||||||||
|
ATP binding cassette subfamily C member 2 | 0.483 | 0.808 | 5.2E-47 |
|
disease | 0.200 | None | 1.000 | 2 | 0 | 2004 | 2014 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
disease | 0.300 | None | 0.935 | 2 | 0 | 2004 | 2019 | ||||||||
|
protein kinase AMP-activated catalytic subunit alpha 1 | 0.453 | 0.846 | 0.14 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2008 | 2020 | ||||||||
|
UDP glucuronosyltransferase family 1 member A6 | 0.560 | 0.654 | 3.0E-07 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2013 | 2015 | ||||||||
|
BCL2 associated agonist of cell death | 0.553 | 0.769 | 4.6E-03 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
protein kinase C epsilon | 0.597 | 0.692 | 1.00 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2015 | 2018 | ||||||||
|
UDP glucuronosyltransferase family 1 member A1 | 0.464 | 0.769 | 3.3E-06 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2013 | 2015 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.700 | None | 1.000 | 1 | 0 | 2002 | 2020 | ||||||||
|
mitogen-activated protein kinase 9 | 0.561 | 0.731 | 7.0E-02 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2011 | 2018 |